![N-{3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl}-2,1,3-benzothiadiazole-4-sulfonamide](https://static.cymitquimica.com/cas-image/369762-n-3-oxo-3-4-4-pyridinyl-1-piperazinyl-propyl-213-benzothiadiazole-4-sulfonamide.png)
CAS: 1135243-19-4 - N-{3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl}-2,1,3-benzothiadiazole-4-sulfonamide
Formula:C18H20N6O3S2
InChI:InChI=1S/C18H20N6O3S2/c25-17(24-12-10-23(11-13-24)14-4-7-19-8-5-14)6-9-20-29(26,27)16-3-1-2-15-18(16)22-28-21-15/h1-5,7-8,20H,6,9-13H2
![2,1,3-Benzothiadiazole-4-sulfonamide, N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-](https://static.cymitquimica.com/products/IN/thumb/DA0008W7.jpg)
2,1,3-Benzothiadiazole-4-sulfonamide, N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-
CAS:1135243-19-4
Formula:
C18H20N6O3S2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
432.5198
Ref: IN-DA0008W7
| 25mg | 51.00 € | ||
| 100mg | 109.00 € | ||
| 250mg | 152.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
VU 0255035
CAS:1135243-19-4
VU0255035 is a drug that blocks the muscarinic acetylcholine receptor, which is used to treat …
Formula:
C18H20N6O3S2
Purity:
Min. 95%
Molecular weight:
432.52 g/mol
Ref: 3D-KVB24319
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
VU 0255035
CAS:1135243-19-4
VU 0255035 is a highly selective, competitive and brain penetrant muscarinic M1 receptor antagonist with …
Formula:
C18H20N6O3S2
Purity:
96.53% - 98.26%
Color and Shape:
Solid
Molecular weight:
432.52
Ref: TM-T23508
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 243.00 € | ||
| 50mg | 362.00 € | ||
| 100mg | 532.00 € | ||
| 500mg | 1,095.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
